0
ARTICLE |

Pathology and Laboratory Medicine FREE

Robert L. Reddick, MD; William W. McLendon, MD
JAMA. 1992;268(3):397-399. doi:10.1001/jama.1992.03490030109048
Text Size: A A A
Published online

In the last year, the development and use of new methods to improve diagnostic acumen in anatomic pathology have continued to be major endeavors. One of the most exciting new techniques is the polymerase chain reaction (PCR). This technology allows the synthesis of multiple copies of DNA from extremely small starting samples of DNA or RNA. Polymerase chain reaction has been performed on single cells, blood spots, embryos, and tissues embedded in paraffin blocks.1 In diagnostic pathology, PCR has been used to document the presence of Epstein-Barr virus sequences in Hodgkin's disease2; to study lineage and clonality in lymphomas3 and gene rearrangements in B- and T-lymphoproliferative disorders4; and to detect human T-cell leukemialymphoma viruses.5 The PCR technology performed on the DNA extracted from chorionic villi has been used for the prenatal diagnosis of genetic diseases, such as cystic fibrosis and β-thalassemia.6 Such an approach

REFERENCES

Wright PA, Wynford-Thomas D.  The polymerase chain reaction: miracle or mirage? a critical review of its uses and limitations in diagnosis and research. J Pathol . 1990;;162:99-117.
Knecht H, Obermatt BF, Bachman NE, et al.  Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood . 1991;;78:760-767.
Lardelli P, Swaby RF, Medeiros LJ, Jaffe ES, Rizzi R, Stetler-Stevenson M.  Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction techniques. Hum Pathol . 1991;;22:685-689.
Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA.  Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood . 1991;;78:192-196.
Hjelle B.  Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med . 1991;;115:440-450.
Lindeman R, Wallace R, Volpato F, Hu SP, Trent RJ.  Utility of the polymerase chain reaction (PCR) for prenatal diagnosis of genetic disease. Pathology . 1991;;23:158-163.
Hindkjaer J, Koch J, Mogensen J, et al.  Primed in situ labelling of nucleic acids: a technique for gene mapping, diagnostics, and functional cytogenetics. Biotech Forum Europe . 1991;;8:752-756.
Nuovo GJ, Gallery F, MacConnell P, Becker J, Bloch W.  An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol . 1991;;139:1239-1244.
Roald B, Brandtzaeg P.  Immunohistochemistry on needle biopsies of childhood malignancies. Pathol Res Prac . 1991;;187:917-923.
Silverman LM, Highsmith WE Jr.  Automation and the single-gene disorder: cystic fibrosis as a model. Clin Chem . 1992;;38:7-8.
College of American Pathologists Conference XIX.  The examination of the placenta: patient care and risk management. Arch Pathol Lab Med . 1991;;115:660-721.
Altshuler G, Deppisch LM.  College of American Pathologist Conference XIX on the Examination of the Placenta: report of the working group on indications for placental examination. Arch Pathol Lab Med . 1991;;115:701-703.
Naeye RL. Disorders of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance . St Louis, Mo: Mosby—Year Book; 1991;.
Hardy K, Handyside AH.  Biopsy of cleavage stage human embryos and diagnosis of single gene defects by DNA amplification. Arch Pathol Lab Med . 1992;;116:388-392.
Negrin RS, Kiem HP, Schmidt-Wolf IG, Blume KG, Cleary ML.  Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. Blood . 1991;;77:654-660.
Ziegler EJ, Fisher Jr CJ, Sprung CL, et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med . 1991;;324:429-436.
Wilson ML, Winstein MP, Reimer LG, Mirrett S, Reller LB.  Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol . 1992;;30: 323-329.
Weinstein RS, Kuszak JR, Kluskens LF, Coon JS.  P-Glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol . 1990;;21:34-48.
Haber DA.  Multidrug resistance (MDR1) in leukemia: is it time to test? Blood . 1992;;79:295-298.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Wright PA, Wynford-Thomas D.  The polymerase chain reaction: miracle or mirage? a critical review of its uses and limitations in diagnosis and research. J Pathol . 1990;;162:99-117.
Knecht H, Obermatt BF, Bachman NE, et al.  Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood . 1991;;78:760-767.
Lardelli P, Swaby RF, Medeiros LJ, Jaffe ES, Rizzi R, Stetler-Stevenson M.  Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction techniques. Hum Pathol . 1991;;22:685-689.
Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA.  Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood . 1991;;78:192-196.
Hjelle B.  Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med . 1991;;115:440-450.
Lindeman R, Wallace R, Volpato F, Hu SP, Trent RJ.  Utility of the polymerase chain reaction (PCR) for prenatal diagnosis of genetic disease. Pathology . 1991;;23:158-163.
Hindkjaer J, Koch J, Mogensen J, et al.  Primed in situ labelling of nucleic acids: a technique for gene mapping, diagnostics, and functional cytogenetics. Biotech Forum Europe . 1991;;8:752-756.
Nuovo GJ, Gallery F, MacConnell P, Becker J, Bloch W.  An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol . 1991;;139:1239-1244.
Roald B, Brandtzaeg P.  Immunohistochemistry on needle biopsies of childhood malignancies. Pathol Res Prac . 1991;;187:917-923.
Silverman LM, Highsmith WE Jr.  Automation and the single-gene disorder: cystic fibrosis as a model. Clin Chem . 1992;;38:7-8.
College of American Pathologists Conference XIX.  The examination of the placenta: patient care and risk management. Arch Pathol Lab Med . 1991;;115:660-721.
Altshuler G, Deppisch LM.  College of American Pathologist Conference XIX on the Examination of the Placenta: report of the working group on indications for placental examination. Arch Pathol Lab Med . 1991;;115:701-703.
Naeye RL. Disorders of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance . St Louis, Mo: Mosby—Year Book; 1991;.
Hardy K, Handyside AH.  Biopsy of cleavage stage human embryos and diagnosis of single gene defects by DNA amplification. Arch Pathol Lab Med . 1992;;116:388-392.
Negrin RS, Kiem HP, Schmidt-Wolf IG, Blume KG, Cleary ML.  Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. Blood . 1991;;77:654-660.
Ziegler EJ, Fisher Jr CJ, Sprung CL, et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med . 1991;;324:429-436.
Wilson ML, Winstein MP, Reimer LG, Mirrett S, Reller LB.  Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol . 1992;;30: 323-329.
Weinstein RS, Kuszak JR, Kluskens LF, Coon JS.  P-Glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol . 1990;;21:34-48.
Haber DA.  Multidrug resistance (MDR1) in leukemia: is it time to test? Blood . 1992;;79:295-298.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.